Literature DB >> 30503082

The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem.

Alberto Ortiz1, Maria Dolores Sanchez-Niño2, Marta Crespo-Barrio3, Patricia De-Sequera-Ortiz4, Elvira Fernández-Giráldez5, Rafael García-Maset6, Manuel Macía-Heras7, Miguel Pérez-Fontán8, Mariano Rodríguez-Portillo9, Mercedes Salgueira-Lazo10, Emilio Sánchez-Álvarez11, Rafael Santamaría-Olmo9, Fernando Simal-Blanco12, Maria Dolores Pino-Pino13.   

Abstract

The Global Burden of Disease (GBD) study measures the health of populations worldwide and by country on an annual basis and aims at helping guide public policy on health issues. The GBD estimates for Spain in 2016 and recent trends in mortality and morbidity from 2006 to 2016 were recently published. According to these estimates, chronic kidney disease was the 8th cause of death in Spain in 2016. Among the top ten causes of death, chronic kidney disease was the fastest growing from 2006 to 2016, after Alzheimer disease. At the current pace of growth, chronic kidney disease is set to become the second cause of death in Spain, after Alzheimer disease, by 2100. Additionally, among major causes of death, chronic kidney disease also ranked second only to Alzheimer as the fastest growing cause of Years Lived with Disability (YLDs) and Disability Adjusted Life Years (DALYs). Public resources devoted to prevention, care and research on kidney disease should be in line with both its current and future burden.
Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Clasificación; Enfermedad renal crónica; Financiación de la investigación; Mortalidad; Mortality; Public health; Ranking; Research funding; Salud pública

Mesh:

Year:  2018        PMID: 30503082     DOI: 10.1016/j.nefro.2018.09.002

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN: 2013-2514


  18 in total

1.  Stopping kidney protection in the elderly following acute kidney injury: think mortality.

Authors:  Sol Carriazo; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2022-02-02

2.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia (Engl Ed)       Date:  2022 Jan-Feb

3.  Expanding congenital abnormalities of the kidney and urinary tract (CAKUT) genetics: basonuclin 2 (BNC2) and lower urinary tract obstruction.

Authors:  Raul Fernandez-Prado; Mehmet Kanbay; Alberto Ortiz; Maria Vanessa Perez-Gomez
Journal:  Ann Transl Med       Date:  2019-09

4.  Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Authors:  Beatriz Fernandez-Fernandez; Raul Fernandez-Prado; Jose Luis Górriz; Alberto Martinez-Castelao; Juan F Navarro-González; Esteban Porrini; María José Soler; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2019-05-31

Review 5.  Chronodisruption: A Poorly Recognized Feature of CKD.

Authors:  Sol Carriazo; Adrián M Ramos; Ana B Sanz; Maria Dolores Sanchez-Niño; Mehmet Kanbay; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2020-02-28       Impact factor: 4.546

6.  A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease.

Authors:  Mehmet Kanbay; Aslihan Yerlikaya; Alan A Sag; Alberto Ortiz; Masanari Kuwabara; Adrian Covic; Andrzej Wiecek; Peter Stenvinkel; Baris Afsar
Journal:  Clin Kidney J       Date:  2019-09-18

Review 7.  Phosphate, Microbiota and CKD.

Authors:  Chiara Favero; Sol Carriazo; Leticia Cuarental; Raul Fernandez-Prado; Elena Gomá-Garcés; Maria Vanessa Perez-Gomez; Alberto Ortiz; Beatriz Fernandez-Fernandez; Maria Dolores Sanchez-Niño
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

Review 8.  Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors:  Carolina Lavoz; Sandra Rayego-Mateos; Macarena Orejudo; Lucas Opazo-Ríos; Vanessa Marchant; Laura Marquez-Exposito; Antonio Tejera-Muñoz; Juan F Navarro-González; Alejandra Droguett; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

9.  Diabetes mellitus: a single cardiorenal syndrome umbrella.

Authors:  Eva Rodríguez; Carlos Arias-Cabrales; Julio Pascual
Journal:  Clin Kidney J       Date:  2019-11-26

10.  Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients.

Authors:  Yan-Zhuan Xiao; Zhi-Zhong Ye; Yuan-Tong Liang; Xin-Peng Chen; Yu-Hsun Wang; Qiang Xu; James Cheng-Chung Wei
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.